Vanguard Group
TNXP icon

Vanguard Group’s Tonix Pharmaceuticals TNXP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$5.93M Buy
164,732
+73,236
+80% +$2.64M ﹤0.01% 3154
2025
Q1
$1.64M Buy
+91,496
New +$1.64M ﹤0.01% 3558
2024
Q3
Sell
-25,395
Closed -$17.7K 4384
2024
Q2
$17.7K Sell
25,395
-505,464
-95% -$353K ﹤0.01% 4363
2024
Q1
$98.7K Buy
530,859
+125,414
+31% +$23.3K ﹤0.01% 4245
2023
Q4
$163K Buy
405,445
+7,300
+2% +$2.94K ﹤0.01% 4246
2023
Q3
$217K Sell
398,145
-609
-0.2% -$332 ﹤0.01% 4243
2023
Q2
$630K Sell
398,754
-2,029,024
-84% -$3.21M ﹤0.01% 4051
2023
Q1
$1.44M Buy
2,427,778
+1,452,782
+149% +$859K ﹤0.01% 3792
2022
Q4
$380K Buy
974,996
+116,580
+14% +$45.4K ﹤0.01% 4176
2022
Q3
$459K Buy
858,416
+126,236
+17% +$67.5K ﹤0.01% 4240
2022
Q2
$1.16M Sell
732,180
-17,576,646
-96% -$27.8M ﹤0.01% 4039
2022
Q1
$4.22M Sell
18,308,826
-1,318,154
-7% -$303K ﹤0.01% 3615
2021
Q4
$7.02M Buy
19,626,980
+3,620,360
+23% +$1.3M ﹤0.01% 3426
2021
Q3
$9.62M Buy
16,006,620
+240,081
+2% +$144K ﹤0.01% 3263
2021
Q2
$17.5M Buy
15,766,539
+1,088,377
+7% +$1.21M ﹤0.01% 2917
2021
Q1
$18.8M Buy
14,678,162
+12,862,323
+708% +$16.5M ﹤0.01% 2815
2020
Q4
$1.23M Buy
1,815,839
+1,300,380
+252% +$877K ﹤0.01% 3782
2020
Q3
$433K Buy
515,459
+132,375
+35% +$111K ﹤0.01% 3839
2020
Q2
$234K Hold
383,084
﹤0.01% 3906
2020
Q1
$272K Buy
+383,084
New +$272K ﹤0.01% 3813
2019
Q4
Sell
-85,037
Closed -$34K 4136
2019
Q3
$34K Hold
85,037
﹤0.01% 4106
2019
Q2
$117K Buy
+85,037
New +$117K ﹤0.01% 4038
2018
Q4
Sell
-202,062
Closed -$119K 4158
2018
Q3
$119K Sell
202,062
-20,191
-9% -$11.9K ﹤0.01% 4056
2018
Q2
$989K Buy
222,253
+23,716
+12% +$106K ﹤0.01% 3693
2018
Q1
$584K Buy
198,537
+29,091
+17% +$85.6K ﹤0.01% 3758
2017
Q4
$585K Buy
169,446
+10,053
+6% +$34.7K ﹤0.01% 3710
2017
Q3
$727K Sell
159,393
-24,984
-14% -$114K ﹤0.01% 3672
2017
Q2
$799K Buy
184,377
+41,264
+29% +$179K ﹤0.01% 3620
2017
Q1
$668K Sell
143,113
-389,342
-73% -$1.82M ﹤0.01% 3689
2016
Q4
$250K Sell
532,455
-244,985
-32% -$115K ﹤0.01% 3857
2016
Q3
$542K Buy
777,440
+70,375
+10% +$49.1K ﹤0.01% 3744
2016
Q2
$1.41M Buy
707,065
+10,531
+2% +$21K ﹤0.01% 3503
2016
Q1
$1.68M Buy
696,534
+206,954
+42% +$499K ﹤0.01% 3442
2015
Q4
$3.76M Buy
489,580
+40,706
+9% +$312K ﹤0.01% 3114
2015
Q3
$2.38M Buy
448,874
+86,514
+24% +$458K ﹤0.01% 3296
2015
Q2
$3.25M Buy
362,360
+11,400
+3% +$102K ﹤0.01% 3203
2015
Q1
$2.22M Buy
350,960
+106,800
+44% +$675K ﹤0.01% 3360
2014
Q4
$1.43M Buy
244,160
+7,100
+3% +$41.5K ﹤0.01% 3406
2014
Q3
$1.62M Buy
237,060
+37,147
+19% +$254K ﹤0.01% 3348
2014
Q2
$2.87M Buy
199,913
+5,400
+3% +$77.5K ﹤0.01% 3095
2014
Q1
$2.03M Buy
194,513
+157,323
+423% +$1.64M ﹤0.01% 3215
2013
Q4
$384K Buy
+37,190
New +$384K ﹤0.01% 3650